Literature DB >> 11938356

Hepatitis C virus genotypes in Saudi Arabia.

Abimbola O Osoba1.   

Abstract

Hepatitis C virus genotypes have been associated with specific geographical areas and in many cases with specific mode of transmission. In developed countries, genotype determination has formed a part of the management of patients with hepatitis C virus seropositivity and liver diseases due to hepatitis C virus. The epidemiology of hepatitis C virus has been shown to be changing rapidly in many countries due to population movement and different life-styles; hence the distribution of the genotypes is being monitored closely in many countries. In the Kingdom of Saudi Arabia, there are only a handful of publications recording the hepatitis C virus genotypes in various population groups. These studies have been carried out mainly in Riyadh (Central province) and Jeddah (Western province). There are no studies emanating from the Eastern or Northern provinces. According to these studies, the most prevalent genotype in the Western Province and probably in the whole Kingdom of Saudi Arabia was genotype 4, followed by genotypes 1a and 1b. Genotypes 1, 2a,/2b, 3 and 6 are very rare in the Kingdom of Saudi Arabia. Genotype 5 was identified exclusively in the Western province and nowhere else. Genotypes 1b and 4 were associated with different histological grades of liver disease. Mixed infections with more than one genotype were observed in some studies. More detailed epidemiological studies of hepatitis C virus infections are needed in the Kingdom of Saudi Arabia to gain more insight into a possible type/subtype-specific pathogenesis of hepatitis C virus in the different regions of the Kingdom of Saudi Arabia as well as the distribution of the genotypes in the various localities.

Entities:  

Mesh:

Year:  2002        PMID: 11938356

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  13 in total

1.  Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report.

Authors:  M D Aljurf; S Z Zaidi; H El Solh; F Hussain; A Ghavamzadeh; H K Mahmoud; T Shamsi; T Ben Othman; M M Sarhan; D Dennison; A Ibrahim; S Benchekroun; N Chaudhri; B Labar; M Horowitz; D Niederwieser; A Gratwohl
Journal:  Bone Marrow Transplant       Date:  2008-12-01       Impact factor: 5.483

Review 2.  Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.

Authors:  S Ramia; N M Melhem; K Kreidieh
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

3.  Prevalence and impact of hepatic steatosis on the response to antiviral therapy in Saudi patients with genotypes 1 and 4 chronic hepatitis C.

Authors:  Abdallah M AlQaraawi; Faisal M Sanai; Hussa Al-Husseini; Ali Albenmousa; Abdulmalik AlSheikh; Lubna Rizwan Ahmed; Ahmad Hersi; Molfi M Al-Otaibi; Mohammed Syed; Safiyya M Ali; Waleed Al-hamoudi; Khalid A Alswat; Ayman A Abdo
Journal:  Dig Dis Sci       Date:  2010-10-08       Impact factor: 3.199

Review 4.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

5.  Epidemiology of hepatitis C virus (HCV) infection.

Authors:  Theodore Sy; M Mazen Jamal
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

6.  Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4.

Authors:  Hamad Al Ashgar; Ahmed Helmy; Mohamed Q Khan; Khalid Al Kahtani; Mohammed Al Quaiz; Mohammed Rezeig; Ingvar Kagevi; Abdullah Alshehri; Abdullah Al Kalbani; Khalid Al Swat; Salim Dahab; Naser Elkum; Mohammed Al Fadda
Journal:  Ann Saudi Med       Date:  2009 Jan-Feb       Impact factor: 1.526

7.  Recurrence of hepatitis C virus genotype-4 infection following orthotopic liver transplantation: natural history and predictors of outcome.

Authors:  Hatim Mudawi; Ahmed Helmy; Yasser Kamel; Mohammed Al Saghier; Mohammed Al Sofayan; Mohammed Al Sebayel; Hatem Khalaf; Hamad Al Bahili; Yasser Al Shiek; Khalil Alawi; Ahmed Aljedai; Hazem Mohamed; Waleed Al Hamoudi; Ayman Abdo
Journal:  Ann Saudi Med       Date:  2009 Mar-Apr       Impact factor: 1.526

8.  Hepatitis C genotype 4: genotypic diversity, epidemiological profile, and clinical relevance of subtypes in Saudi Arabia.

Authors:  Hamad I Al Ashgar; Mohammed Q Khan; Mohammed Al-Ahdal; Sahar Al Thawadi; Ahmad Salem Helmy; Ahmed Al Qahtani; Faisal M Sanai
Journal:  Saudi J Gastroenterol       Date:  2013 Jan-Feb       Impact factor: 2.485

Review 9.  Hepatocellular carcinoma in the world and the middle East.

Authors:  H Poustchi; Sg Sepanlou; S Esmaili; N Mehrabi; A Ansarymoghadam
Journal:  Middle East J Dig Dis       Date:  2010-01

10.  Genotypic analysis of hepatitis C virus in khuzestan province, southwestern iran.

Authors:  Eskandar Hajiani; Seyed Jalal Hashemi; Abdolrahim Masjedizadeh; Ali Akbar Shayesteh; Fariba Jalali
Journal:  Middle East J Dig Dis       Date:  2011-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.